Cargando…
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway
BACKGROUND: Circular RNAs (circRNAs) are gradually reported to be implicated in the development of malignant tumors, including ovarian cancer (OC). This paper intended to explore the function and action mechanism of hsa_circ_0004712 in OC. RESULTS: In our results, hsa_circ_0004712 was aberrantly ove...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434704/ https://www.ncbi.nlm.nih.gov/pubmed/34507595 http://dx.doi.org/10.1186/s13048-021-00859-0 |
_version_ | 1783751661320142848 |
---|---|
author | Zhou, Xuan Jiang, Jinchi Guo, Shuaishuai |
author_facet | Zhou, Xuan Jiang, Jinchi Guo, Shuaishuai |
author_sort | Zhou, Xuan |
collection | PubMed |
description | BACKGROUND: Circular RNAs (circRNAs) are gradually reported to be implicated in the development of malignant tumors, including ovarian cancer (OC). This paper intended to explore the function and action mechanism of hsa_circ_0004712 in OC. RESULTS: In our results, hsa_circ_0004712 was aberrantly overexpressed in OC tissues and cells. Downregulation of hsa_circ_0004712 impaired OC cell proliferation, colony formation, invasion and migration, and accelerated apoptosis. Hsa_circ_0004712 directly targeted miR-331-3p whose inhibitors reversed the effects of hsa_circ_0004712 downregulation. FZD4 was targeted by miR-331-3p, and hsa_circ_0004712 could positively regulated FZD4 expression by targeting miR-331-3p. The anti-tumor effects of miR-331-3p restoration were reversed by FZD4 overexpression. Downregulation of hsa_circ_0004712 also impaired tumor development in vivo by regulating miR-331-3p and FZD4. CONCLUSION: In conclusion, hsa_circ_0004712 deficiency repressed OC development by mediating the miR-331-3p/FZD4 pathway, predicting that hsa_circ_0004712 was a promising biomarker for OC diagnosis and therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13048-021-00859-0. |
format | Online Article Text |
id | pubmed-8434704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84347042021-09-13 Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway Zhou, Xuan Jiang, Jinchi Guo, Shuaishuai J Ovarian Res Research BACKGROUND: Circular RNAs (circRNAs) are gradually reported to be implicated in the development of malignant tumors, including ovarian cancer (OC). This paper intended to explore the function and action mechanism of hsa_circ_0004712 in OC. RESULTS: In our results, hsa_circ_0004712 was aberrantly overexpressed in OC tissues and cells. Downregulation of hsa_circ_0004712 impaired OC cell proliferation, colony formation, invasion and migration, and accelerated apoptosis. Hsa_circ_0004712 directly targeted miR-331-3p whose inhibitors reversed the effects of hsa_circ_0004712 downregulation. FZD4 was targeted by miR-331-3p, and hsa_circ_0004712 could positively regulated FZD4 expression by targeting miR-331-3p. The anti-tumor effects of miR-331-3p restoration were reversed by FZD4 overexpression. Downregulation of hsa_circ_0004712 also impaired tumor development in vivo by regulating miR-331-3p and FZD4. CONCLUSION: In conclusion, hsa_circ_0004712 deficiency repressed OC development by mediating the miR-331-3p/FZD4 pathway, predicting that hsa_circ_0004712 was a promising biomarker for OC diagnosis and therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13048-021-00859-0. BioMed Central 2021-09-10 /pmc/articles/PMC8434704/ /pubmed/34507595 http://dx.doi.org/10.1186/s13048-021-00859-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhou, Xuan Jiang, Jinchi Guo, Shuaishuai Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway |
title | Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway |
title_full | Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway |
title_fullStr | Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway |
title_full_unstemmed | Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway |
title_short | Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway |
title_sort | hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the mir-331-3p/fzd4 pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434704/ https://www.ncbi.nlm.nih.gov/pubmed/34507595 http://dx.doi.org/10.1186/s13048-021-00859-0 |
work_keys_str_mv | AT zhouxuan hsacirc0004712downregulationattenuatesovariancancermalignantdevelopmentbytargetingthemir3313pfzd4pathway AT jiangjinchi hsacirc0004712downregulationattenuatesovariancancermalignantdevelopmentbytargetingthemir3313pfzd4pathway AT guoshuaishuai hsacirc0004712downregulationattenuatesovariancancermalignantdevelopmentbytargetingthemir3313pfzd4pathway |